Bio Works (Sweden) Today
| BIOWKS Stock | SEK 4.10 0.01 0.24% |
Performance0 of 100
| Odds Of DistressOver 65
|
Bio Works is trading at 4.10 as of the 16th of April 2024, a 0.24% increase since the beginning of the trading day. The stock's open price was 4.09. Bio Works has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Bio Works Technologies AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 17th of March 2024 and ending today, the 16th of April 2024. Click here to learn more.
Bio-Works Technologies AB researches, develops, manufactures, and supplies agarose based resins used to separate proteins and other biomolecules. Bio-Works Technologies AB founded in 2006 and is based in Uppsala, Sweden. Bio Works is traded on Stockholm Stock Exchange in Sweden. The company has 34.87 M outstanding shares. More on Bio Works Technologies AB
Moving together with Bio Stock
| 0.88 | GENO | Genovis AB | PairCorr |
| 0.66 | HNSA | Hansa Biopharma AB Earnings Call This Week | PairCorr |
Moving against Bio Stock
| 0.91 | INVE-A | Investor AB ser | PairCorr |
| 0.9 | INVE-B | Investor AB ser | PairCorr |
| 0.89 | SWED-A | Swedbank AB | PairCorr |
| 0.89 | ATCO-A | Atlas Copco AB | PairCorr |
| 0.88 | ATCO-B | Atlas Copco AB | PairCorr |
| 0.88 | LIAB | Lindab International | PairCorr |
| 0.75 | XSPRAY | XSpray Pharma AB | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bio Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bio Works' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bio Works or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Biotechnology, Healthcare, Computing (View all Sectors) |
Bio Works Technologies AB (BIOWKS) is traded on Stockholm Exchange in Sweden and employs 36 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 718.4 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bio Works's market, we take the total number of its shares issued and multiply it by Bio Works's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bio Works Technologies operates under Healthcare sector and is part of Biotechnology industry. The entity has 34.87 M outstanding shares.
Bio Works Technologies AB has accumulated about 46.35 M in cash with (13.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.4.
Check Bio Works Probability Of Bankruptcy
Ownership AllocationBio Works Technologies retains a total of 34.87 Million outstanding shares. Bio Works Technologies AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Bio Ownership Details
Bio Stock Price Odds Analysis
What are Bio Works' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Bio Works jumping above the current price in 90 days from now is about 84.91%. The Bio Works Technologies AB probability density function shows the probability of Bio Works stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Bio Works Technologies AB has a beta of -0.3424 suggesting as returns on the benchmark increase, returns on holding Bio Works are expected to decrease at a much lower rate. During a bear market, however, Bio Works Technologies AB is likely to outperform the market. Additionally, bio Works Technologies AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Bio Works to move above the current price in 90 days from now is about 84.91 (This Bio Works Technologies AB probability density function shows the probability of Bio Stock to fall within a particular range of prices over 90 days) .
Bio Works Technologies Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bio Works market risk premium is the additional return an investor will receive from holding Bio Works long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bio Works. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Bio Works' alpha and beta are two of the key measurements used to evaluate Bio Works' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.47 | |||
| Standard Deviation | 5.23 | |||
| Variance | 27.34 | |||
| Risk Adjusted Performance | (0.07) |
Bio Stock Against Markets
Picking the right benchmark for Bio Works stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bio Works stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bio Works is critical whether you are bullish or bearish towards Bio Works Technologies AB at a given time. Please also check how Bio Works' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bio Works without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Bio Works Corporate Management
Elected by the shareholders, the Bio Works' board of directors comprises two types of representatives: Bio Works inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bio. The board's role is to monitor Bio Works' management team and ensure that shareholders' interests are well served. Bio Works' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bio Works' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sara Ekvall | Director Culture | Profile | |
| Anna Lindqvist | Chief Officer | Profile | |
| Jonathan Royce | Chief Officer | Profile | |
| David Nelander | Chief Officer | Profile | |
| Helena Pahlm | Director Quality | Profile | |
| Jan Berglf | CoFounder Advisor | Profile | |
| Karsten Fjrstedt | Chief Officer | Profile |
How to buy Bio Stock?
Before investing in Bio Works, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Bio Works. To buy Bio Works stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Bio Works. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Bio Works stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Bio Works Technologies AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Bio Works Technologies AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Bio Works Technologies AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Bio Works Technologies AB?
The danger of trading Bio Works Technologies AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bio Works is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bio Works. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bio Works Technologies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Works Technologies AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Bio Stock analysis
When running Bio Works' price analysis, check to measure Bio Works' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Works is operating at the current time. Most of Bio Works' value examination focuses on studying past and present price action to predict the probability of Bio Works' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Works' price. Additionally, you may evaluate how the addition of Bio Works to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |